Research and development
Formulation research and process development, carried out to the Code of Good Clinical Practice for pharmaceuticals.
Manufacturing
A medicine programme needs more than an idea. It needs people who can turn research into a repeatable process. That is the work our team is building on in Sydney.
Based in Thornleigh, Sydney
TCann's manufacturing work brings together production, quality assurance and process development. The facility is operated by TCann Pty Ltd and supports the company's own development programme alongside work for other pharmaceutical organisations.
The 800 m² site is the base for the next stage of tablet manufacturing. Proposed investment includes equipment, process validation and cleanroom upgrades to support production at greater scale.
Source: OnMarket company information, accessed 22 September 2026.
The work involved
Formulation research and process development, carried out to the Code of Good Clinical Practice for pharmaceuticals.
Manufacturing to the Code of Good Manufacturing Practice for pharmaceuticals, overseen by highly qualified regulatory staff.
Packaging and labelling that meets the requirements of Medicines Australia and the Therapeutic Goods Act. Tested and retested, the tablet has a three-year shelf life, because a tablet doesn't degrade the way oils do.
Adding the equipment and automation to bring the facility to global scale.
Preparing to unify Australia's supply chain, from seed through agribusiness to pharmaceutical manufacture and export. We can take Australian-grown cannabis and extract every part of the plant into our tablets.
Inside the team